MedTrace Logo

CPAP vs ASV for Insomnia

NCT02365064 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2021-09-09

Study results available
· View outcomes & findings →

Summary

The study will determine which of two different types of positive airway pressure (PAP therapy) modes are more effective in reducing sleep breathing events in chronic insomnia patients and in decreasing insomnia severity.

Conditions

Interventions

DEVICE

AirCurve 10 ASV

Device is able to provide both ASV therapy and CPAP therapy modes.

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Principal Investigators

  • Barry Krakow, MD · Sleep & Human Health Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-08-31
Completion
2017-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02365064 on ClinicalTrials.gov